Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study.
Saved in:
| Title: | Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study. |
|---|---|
| Authors: | Lee, Wei1,2,3,4 (AUTHOR) Wei.lee@health.nsw.gov.au, Sheehan, Caitlin5 (AUTHOR), Chye, Richard1,2,6,7 (AUTHOR), Chang, Sungwon1 (AUTHOR), Bayes, Adam7,8 (AUTHOR), Loo, Colleen7,8 (AUTHOR), Draper, Brian7 (AUTHOR), Agar, Meera R.1,7 (AUTHOR), Currow, David C.9 (AUTHOR) |
| Source: | PLoS ONE. 11/14/2023, Vol. 18 Issue 11, p1-17. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0290876 |
